scholarly journals Phase II study of paclitaxel in patients with advanced gastrointestinal stromal tumor (GIST) after failure of at least both imatinib and sunitinib

2018 ◽  
Vol 29 ◽  
pp. viii583
Author(s):  
H. Cho ◽  
M.-H. Ryu ◽  
B.J. Kim ◽  
Y. Park ◽  
Y.-S. Na ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stromal Tumor

scholarly journals Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study

2019 ◽  
Vol 30 ◽  
pp. vi88
Author(s):  
Yoichi Naito ◽  
Toshihiko Doi ◽  
Tsuyoshi Takahashi ◽  
Toshihiro Kudo ◽  
Narikazu Boku ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stromal Tumor ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Imatinib Resistant

A phase II study of dasatinib for patients with imatinib-resistant gastrointestinal stromal tumor (GIST).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 10006-10006 ◽  
Author(s):  
J. C. Trent ◽  
K. Wathen ◽  
M. von Mehren ◽  
B. L. Samuels ◽  
A. P. Staddon ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stromal Tumor ◽  
Imatinib Resistant
Sign in / Sign up

Export Citation Format

Share Document